Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Research Article - Biomedical Research (2017) Volume 28, Issue 22

The expression difference of CEA, CA19-9, CA72-4 and CA125 in patients with different staging of gastric cancer and the relationship with metastasis and recurrence

Objective: To analyse the expression difference of Carcino-Embryonic Antigen (CEA), Carbohydrate Antigen 72-4 (CA72-4), CA19-9, and CA125 in patients with different staging of Gastric Cancer (GC) and the relationship with metastasis and recurrence.

Methods: 284 cases of GC patients with surgery were selected from July 2013 to June 2014 in our hospital. After follower-up of 3 y, the metastasis and recurrence of GC patients was observed. And the expressions of CEA, CA19-9, CA72-4 and CA125 antigens in GC patients with different staging were measured. The relationship of CEA, CA19-9, CA72-4 and CA125 with metastasis and recurrence was analysed.

Results: The positive expression rates and the mean serum levels of CEA, CA19-9, CA72-4 and CA125 in T3/T4 staging GC patients were both higher than T1/T2 staging GC patients (P<0.05). And the positive expression rates and the mean serum levels of CEA, CA19-9, CA72-4 and CA125 antigens in T1/T2/T3 patients after surgery for 3 months were decreased than before surgery (P<0.05). After followed-up of 3 y, the positive expression rates of CEA, CA19-9, CA72-4 and CA125 antigens of patients with metastasis and recurrence before surgery were higher than patients without metastasis and recurrence (P<0.05).

Conclusion: The expressions of CEA, CA19-9, CA72-4 and CA125 antigens in patients with gastric cancer could be related with different staging, which would be the reference index for the diagnosis and prognosis of gastric cancer.

Author(s): Wang Hongzhi, You Yina

Abstract Full Text PDF

Get the App